Twenty years of the International Society for Cellular Therapies: The past, present and future of cellular therapy clinical development

Cytotherapy

Volumn 16, Issue 4, 2014, Pages S112-S119

  Abbott, Stewart ^a   Mackay, Geoff ^b   Durdy, Matthew ^c   Solomon, Susan ^d   Zylberberg, Claudia ^e  

^a CELGENE CORPORATION   (United States)

^b ORGANOGENESIS INC   (United States)

^c CELL AND GENE THERAPY CATAPULT   (United Kingdom)

^d New York Stem Cell Foundation   (United States)

^e Akron Biotech   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL GROWTH; CELL NUCLEUS TRANSPLANTATION; CLINICAL EFFECTIVENESS; CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; CYTOLOGY; EMBRYONIC STEM CELL; EUROPE; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KNOWLEDGE BASE; MEDICAL LITERATURE; MEDICAL SOCIETY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OLIGODENDROGLIA; PATIENT SAFETY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PUBLICATION; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; UNITED KINGDOM; ARTICLE; BIOLOGICAL THERAPY; HEALTH CARE ORGANIZATION; HISTORY; METHODOLOGY;

CELL- AND TISSUE-BASED THERAPY; HISTORY, 20TH CENTURY; HUMANS; SOCIETIES, SCIENTIFIC;

EID: 84908503915     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.01.001     Document Type: Review

References (15)

1. Lazarus H.M., Haynesworth S.E., Gerson S.L., Rosenthal N.S., Caplan A.I. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995, 16:557-564.
2. Murphy G., Tjoa B., Ragde H., Kenny G., Boynton A. T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. Hum Gene Ther 1993, 4:521-527.
3. Mullen C.A., Snitzer K., Culver K.W., Morgan R.A., Anderson W.F., Blaese R.M. Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: long-term expression in vivo of genes introduced with a retroviral vector. Hum Gene Ther 1996, 7:1123-1129.
4. Blaese R.M., Culver K.W., Chang L., Anderson W.F., Mullen C., Nienhuis A., et al. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Hum Gene Ther 1993, 4:521-527.
5. Mesoblast-Ziopharm/Intrexon press release. Available at Accessed November 2013. http://www.mesoblast.com/news-and-media/news-announcements.
6. Clinicaltrials.gov. Available at Accessed November 2013. http://clinicaltrials.gov/ct2/results?term=cell+therapy+intervention&Search=Search.
7. Cell Therapy Catapult UK Clinical Trials Database. Available at Accessed November 2013. https://ctcatapult.innovateuk.org/documents/2156401/2232869/Clinical-Trials-Database-commen%20.
8. Ellem K.A., O'Rourke M.G., Johnson G.R., Parry G., Misko I.S., Schmidt C.W., et al. Acase report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy. Cancer Immunol Immunother 1997, 44:10-20.
9. Novartis: University of Pennsylvania press release. Available at. Accessed November 2013. http://www.novartis.com/newsroom/media-releases/en/2012/1631944.shtml.
10. bluebirdbio-Celgene-Baylor College of Medicine press release. Available at Accessed November 11, 2013. http://investor.bluebirdbio.com/phoenix.zhtml?c=251820%26p=irol-newsArticle%26ID=1817134%26highlight=
11. Church G.M. From systems biology to synthetic biology. Mol Syst Biol 2005, 1:2005.0032.
12. Isaacs F.J., Dwyer D.J., Collins J.J. RNA synthetic biology. Nat Biotechnol 2006, 24:545-554.
13. Noggle S., Fung H.L., Gore A., Martinez H., Satriani K.C., Prosser R., et al. Human oocytes reprogram somatic cells to a pluripotent state. Nature 2011, 478:70-75.
14. Tachibana M., Amato P., Sparman M., Gutierrez N.M., Tippner-Hedges R., Ma H., et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell 2013, 153:1228-1238.
15. UKNSCN patent watch landscape. Available at Accessed November 2013. http://www.ipo.gov.uk/informatic-stemcells.pdf.